Difference between revisions of "Urine cytopathology"
Jump to navigation
Jump to search
| Line 31: | Line 31: | ||
===Paris system for urinary cytology=== | ===Paris system for urinary cytology=== | ||
Proposed standard reporting terminology:<ref name=pmid27318895>{{Cite journal | last1 = Barkan | first1 = GA. | last2 = Wojcik | first2 = EM. | last3 = Nayar | first3 = R. | last4 = Savic-Prince | first4 = S. | last5 = Quek | first5 = ML. | last6 = Kurtycz | first6 = DF. | last7 = Rosenthal | first7 = DL. | title = The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. | journal = Acta Cytol | volume = | issue = | pages = | month = Jun | year = 2016 | doi = 10.1159/000446270 | PMID = 27318895 }}</ref> | Proposed standard reporting terminology:<ref name=pmid27318895>{{Cite journal | last1 = Barkan | first1 = GA. | last2 = Wojcik | first2 = EM. | last3 = Nayar | first3 = R. | last4 = Savic-Prince | first4 = S. | last5 = Quek | first5 = ML. | last6 = Kurtycz | first6 = DF. | last7 = Rosenthal | first7 = DL. | title = The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. | journal = Acta Cytol | volume = | issue = | pages = | month = Jun | year = 2016 | doi = 10.1159/000446270 | PMID = 27318895 }}</ref> | ||
#Nondiagnostic/unsatisfactory | |||
#Negative for [[urothelial carcinoma|hight-grade urothelial carcinoma]] | |||
#Atypical urothelial cells | |||
#Suspicous for high-grade urothelial carcinoma | |||
#High-grade urothelial carcinoma | |||
#Low-grade urothelial neoplasm | |||
#Other malignancy (includes both primary and secondary) and miscellaneous lesions | |||
==Normal== | ==Normal== | ||